首页> 外文期刊>The Journal of Urology >Overactive bladder changes with time: A 5-year longitudinal followup of changes in overactive bladder symptoms, urodynamic studies and urinary nerve growth factor levels
【24h】

Overactive bladder changes with time: A 5-year longitudinal followup of changes in overactive bladder symptoms, urodynamic studies and urinary nerve growth factor levels

机译:膀胱过度活动症随时间变化:对膀胱过度活动症症状,尿动力学研究和泌尿神经生长因子水平变化进行5年的纵向随访

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose We compared clinical symptoms, urodynamic diagnoses and urinary nerve growth factor levels at baseline and 5 years later in patients with overactive bladder. Materials and Methods Patients diagnosed with overactive bladder at a tertiary teaching hospital who underwent urinary nerve growth factor tests 5 years previously were identified by chart review. Patients were invited to return for symptom evaluation, urodynamic studies and a repeat urinary nerve growth factor test. Changes in overactive bladder subtype, urgency severity score and urodynamic diagnosis were classified as improved, stable or worse. Changes in urinary nerve growth factor/creatinine were compared between baseline and 5 years later according to changes in bladder conditions. Results A total of 30 women and 45 men completed the study. Mean ± SD age was 73.5 ± 10.3 years. Urinary nerve growth factor/creatinine showed no significant difference among patients with improved, stable or worse bladder conditions based on overactive bladder or urgency severity score subtypes. However, urinary nerve growth factor/creatinine was significantly decreased in patients with an improved urodynamic diagnosis (mean 0.94 ± 1.36 vs 0.17 ± 0.19 pg/mg, p = 0.02), significantly increased in patients with a worse urodynamic diagnosis (0.55 ± 0.85 vs 2.08 ± 2.81 pg/mg, p = 0.04) and showed no change in those with a stable urodynamic diagnosis. Multiple linear regression analysis revealed that the change in urodynamic diagnosis was still predictive of the change in urinary nerve growth factor/creatinine after adjusting for age, gender, overactive bladder and urgency severity score subtypes (p = 0.001). Conclusions Urinary nerve growth factor/creatinine did not reflect the changes in bladder conditions based on subjective symptoms. However, the levels reflected dynamic changes in bladder pathophysiology according to urodynamic findings.
机译:目的我们比较了膀胱过度活动症患者在基线和5年后的临床症状,尿动力学诊断和尿神经生长因子水平。材料和方法通过图表审查确定在三级教学医院诊断为膀胱过度活动的患者,这些患者在5年之前接受了尿神经生长因子测试。邀请患者返回进行症状评估,尿流动力学研究和重复的泌尿神经生长因子测试。膀胱过度活动症亚型,尿急程度评分和尿动力学诊断的变化被分类为好转,稳定或恶化。根据膀胱状况的变化,比较基线和5年后尿神经生长因子/肌酐的变化。结果共有30名女性和45名男性完成了这项研究。平均±SD年龄为73.5±10.3岁。根据膀胱过度活动症或尿急程度评分亚型,在膀胱状况改善,稳定或恶化的患者中,尿神经生长因子/肌酐没有显着差异。然而,尿动力学诊断改善的患者尿神经生长因子/肌酐明显降低(平均0.94±1.36 vs 0.17±0.19 pg / mg,p = 0.02),尿动力学诊断较差的患者显着升高(0.55±0.85 vs 2.08±2.81 pg / mg,p = 0.04),尿动力学检查稳定的患者无变化。多元线性回归分析显示,在校正年龄,性别,膀胱过度活动症和尿急程度评分亚型后,尿动力学诊断的改变仍可预测尿神经生长因子/肌酐的改变(p = 0.001)。结论泌尿神经生长因子/肌酐不能反映基于主观症状的膀胱状况的变化。但是,该水平反映了根据尿动力学发现的膀胱病理生理学的动态变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号